-
of new PET probes that can aid in detecting therapy resistance of various tumor lesions in a patient and new approaches for targeted radioligand therapy. Benefits: 401(k) Dental insurance Flexible schedule
-
Clinical Associate Professor University of Iowa Stead Family Department of Pediatrics tammy-wilgenbusch@uiowa.edu University of Iowa is an equal opportunity/affirmative action employer. All qualified
-
which evaluated molecular tumor board assisted care versus usual care for stage IIb-IV Non-Small Cell Lung Cancer (NSCLC) This position will offer numerous opportunities for the right candidate to hone
-
manuscripts, and assisting in the daily operations of the laboratory. The postdoctoral researchers will also be highly encouraged to seek extramural and/or intramural funding to support their innovative
-
will subsequently help us to develop new ligands to specifically treat patients suffering from these common diseases and to develop more precise medications in the future. We will use nanoparticle